Drug Side Effects

DICLOFENAC POTASSIUM TABLETS

DICLOFENAC POTASSIUM TABLETS was reported 3443 times

DICLOFENAC POTASSIUM TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LUPUS VULGARIS 89 0.4384
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 96 0.4138
2 DEEP VEIN THROMBOSIS POSTOPERATIVE 175 0.3359
3 SWOLLEN JOINT COUNT INCREASED 362 0.3181
4 C-REACTIVE PROTEIN 87 0.2939
5 RHEUMATIC FEVER 437 0.2851
6 ORTHOPAEDIC EXAMINATION ABNORMAL 2 0.2500
7 FACET JOINT SYNDROME 193 0.2084
8 DUODENAL ULCER PERFORATION 544 0.1478
9 RHEUMATOID FACTOR POSITIVE 490 0.1373
10 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 517 0.1293
11 GRIP STRENGTH 6 0.1277
12 MUSCULOSKELETAL DEFORMITY 28 0.1239
13 DEAFNESS TRANSITORY 89 0.1176
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 91 0.1123
15 RED BLOOD CELL SEDIMENTATION RATE 28 0.1081
16 DISLOCATION OF VERTEBRA 93 0.0989
17 HELICOBACTER INFECTION 595 0.0959
18 RETINITIS 65 0.0945
19 PERIPHERAL VENOUS DISEASE 173 0.0907
20 PEMPHIGUS 644 0.0790
21 X-RAY ABNORMAL 68 0.0772
22 SWOLLEN JOINT COUNT 6 0.0750
23 RED CELL DISTRIBUTION WIDTH DECREASED 28 0.0745
24 MUSCLE INJURY 332 0.0679
25 HAND DEFORMITY 614 0.0676
26 DEATH NEONATAL 81 0.0674
27 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 242 0.0637
28 FOLLICULITIS 368 0.0626
29 PERICARDITIS 654 0.0586
30 WRIST DEFORMITY 32 0.0582
31 SYNOVITIS 667 0.0495
32 C-REACTIVE PROTEIN ABNORMAL 195 0.0485
33 MEAN PLATELET VOLUME DECREASED 27 0.0426
34 VASCULAR ACCESS COMPLICATION 28 0.0422
35 GLOSSODYNIA 639 0.0374
36 LIP DRY 208 0.0369
37 DRUG TOLERANCE DECREASED 65 0.0341
38 PORPHYRIA ACUTE 20 0.0339
39 WOUND 635 0.0307
40 INTESTINAL DIAPHRAGM DISEASE 5 0.0291
41 AUTOIMMUNE DISORDER 180 0.0288
42 BONE EROSION 72 0.0285
43 SERONEGATIVE ARTHRITIS 18 0.0281
44 SYSTEMIC LUPUS ERYTHEMATOSUS 691 0.0278
45 LIVER INJURY 439 0.0274
46 HYPERCHOLESTEROLAEMIA 186 0.0273
47 FUNCTIONAL GASTROINTESTINAL DISORDER 79 0.0271
48 SHOULDER ARTHROPLASTY 50 0.0262
49 IRRITABLE BOWEL SYNDROME 391 0.0246
50 CONTRAINDICATED PRODUCT ADMINISTERED 568 0.0243
51 FIBROMYALGIA 453 0.0241
52 HIP ARTHROPLASTY 273 0.0237
53 LIVE BIRTH 134 0.0228
54 BURSITIS 190 0.0223
55 JOINT DESTRUCTION 29 0.0222
56 GRIP STRENGTH DECREASED 130 0.0220
57 DUCTUS ARTERIOSUS STENOSIS FOETAL 6 0.0213
58 MEAN CELL VOLUME DECREASED 27 0.0212
59 SPONDYLOARTHROPATHY 10 0.0211
60 JOINT RANGE OF MOTION DECREASED 201 0.0208
61 INTERSTITIAL GRANULOMATOUS DERMATITIS 3 0.0200
62 VASCULAR MALFORMATION 3 0.0197
63 BREAST CANCER STAGE III 88 0.0194
64 MEAN CELL HAEMOGLOBIN DECREASED 28 0.0189
65 PARANASAL CYST 3 0.0186
66 SYNOVIAL DISORDER 7 0.0179
67 PSORIATIC ARTHROPATHY 504 0.0177
68 THERAPEUTIC PRODUCT EFFECT DECREASED 542 0.0169
69 HAPTOGLOBIN INCREASED 2 0.0168
70 SCIATICA 197 0.0167
71 ARTHROPATHY 756 0.0164
72 KNEE ARTHROPLASTY 253 0.0163
73 PRESCRIBED OVERDOSE 245 0.0156
74 TYPE 2 DIABETES MELLITUS 420 0.0152
75 INFUSION SITE REACTION 27 0.0152
76 MATERNAL EXPOSURE TIMING UNSPECIFIED 40 0.0150
77 BLOOD CHOLESTEROL INCREASED 565 0.0149
78 NSAID EXACERBATED RESPIRATORY DISEASE 2 0.0147
79 IMPAIRED HEALING 368 0.0141
80 OBESITY 172 0.0140
81 DISCOMFORT 631 0.0138
82 NAIL OPERATION 4 0.0133
83 INFUSION RELATED REACTION 642 0.0129
84 FOOT OPERATION 49 0.0129
85 EMBOLIA CUTIS MEDICAMENTOSA 8 0.0127
86 PHARYNGITIS 134 0.0126
87 WOUND INFECTION 93 0.0124
88 HEPATIC ENZYME INCREASED 660 0.0123
89 BLISTER 544 0.0122
90 JOINT DISLOCATION 98 0.0116
91 ENDOTHELIAL DYSFUNCTION 2 0.0116
92 GASTROINTESTINAL PAIN 100 0.0115
93 LOWER LIMB FRACTURE 160 0.0109
94 TREATMENT FAILURE 638 0.0101
95 LARYNGITIS 86 0.0101
96 OSTEOARTHRITIS 344 0.0100
97 LOWER RESPIRATORY TRACT INFECTION 331 0.0099
98 ABNORMAL LOSS OF WEIGHT 55 0.0099
99 CENTRAL PAIN SYNDROME 2 0.0099
100 SPINAL STENOSIS 27 0.0099
101 EAR INFECTION 200 0.0098
102 LUPUS-LIKE SYNDROME 68 0.0098
103 MONOCYTE COUNT INCREASED 28 0.0097
104 EXOSTOSIS 70 0.0095
105 KOUNIS SYNDROME 16 0.0094
106 SWELLING 717 0.0094
107 EXCESSIVE EYE BLINKING 12 0.0093
108 RHEUMATOID ARTHRITIS 851 0.0093
109 MILIARIA 12 0.0091
110 DRUG INTOLERANCE 687 0.0090
111 BREAST DISORDER FEMALE 2 0.0087
112 COLONIC STENOSIS 3 0.0087
113 WALKING AID USER 44 0.0086
114 ROTATOR CUFF REPAIR 12 0.0086
115 MUSCULOSKELETAL STIFFNESS 609 0.0084
116 GAIT INABILITY 188 0.0083
117 PULMONARY FIBROSIS 121 0.0083
118 NIGHT SWEATS 208 0.0082
119 STOMATITIS 391 0.0080
120 ANKYLOSING SPONDYLITIS 73 0.0079
121 MATERNAL EXPOSURE DURING PREGNANCY 511 0.0079
122 FOOT DEFORMITY 71 0.0079
123 RED BLOOD CELL SEDIMENTATION RATE INCREASED 71 0.0078
124 GLOMERULONEPHRITIS MINIMAL LESION 4 0.0078
125 DIAPHRAGMATIC HERNIA 4 0.0076
126 MOBILITY DECREASED 413 0.0071
127 INTENTIONAL PRODUCT USE ISSUE 479 0.0070
128 THERAPY NON-RESPONDER 220 0.0070
129 JOINT SWELLING 679 0.0070
130 EYE INJURY 16 0.0070
131 PRESCRIBED UNDERDOSE 110 0.0069
132 GENERAL PHYSICAL HEALTH DETERIORATION 581 0.0067
133 MASTOIDITIS 5 0.0067
134 WHEEZING 289 0.0064
135 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 73 0.0063
136 INJURY 392 0.0062
137 TENOSYNOVITIS STENOSANS 3 0.0062
138 ABDOMINAL DISCOMFORT 828 0.0061
139 NON-ALCOHOLIC STEATOHEPATITIS 6 0.0061
140 FEEDING INTOLERANCE 2 0.0060
141 PHYSICAL DISABILITY 24 0.0060
142 FEEDING DISORDER 84 0.0060
143 BONE MARROW OEDEMA 5 0.0060
144 BLEPHAROSPASM 24 0.0060
145 JOINT ARTHROPLASTY 9 0.0060
146 ROAD TRAFFIC ACCIDENT 204 0.0059
147 DUCTUS ARTERIOSUS PREMATURE CLOSURE 2 0.0059
148 SACROILIITIS 9 0.0059
149 C-REACTIVE PROTEIN INCREASED 169 0.0059
150 SPONDYLITIS 16 0.0058
151 OEDEMA 247 0.0056
152 HIP DEFORMITY 2 0.0056
153 GASTROINTESTINAL DISORDER 343 0.0055
154 SPINAL FUSION SURGERY 17 0.0055
155 ILL-DEFINED DISORDER 255 0.0054
156 DACTYLITIS 4 0.0053
157 ADVERSE REACTION 57 0.0052
158 JOINT EFFUSION 31 0.0052
159 MUSCULOSKELETAL DISORDER 86 0.0052
160 BLOOD CHOLESTEROL 2 0.0052
161 LUNG DISORDER 201 0.0051
162 EXPOSURE DURING PREGNANCY 250 0.0051
163 INFLAMMATION 200 0.0051
164 ADVERSE DRUG REACTION 328 0.0048
165 HEPATIC CIRRHOSIS 68 0.0046
166 SOFT TISSUE INJURY 3 0.0046
167 PREGNANCY 84 0.0046
168 TENDERNESS 41 0.0046
169 HYPERSENSITIVITY 695 0.0045
170 LIVER DISORDER 162 0.0045
171 JOINT STIFFNESS 98 0.0045
172 ALOPECIA 744 0.0045
173 DEAFNESS 94 0.0044
174 HYPOPHAGIA 88 0.0043
175 DISABILITY 69 0.0043
176 CONTUSION 336 0.0042
177 ANTIBIOTIC THERAPY 3 0.0041
178 ALLERGY TO CHEMICALS 4 0.0040
179 FLASHBACK 2 0.0040
180 MUSCULOSKELETAL PAIN 194 0.0040
181 DELIRIUM 111 0.0040
182 BREAST CANCER STAGE II 30 0.0040
183 ENTHESOPATHY 5 0.0039
184 HAEMANGIOMA 7 0.0038
185 ONYCHOMYCOSIS 12 0.0038
186 PRODUCT USE ISSUE 552 0.0038
187 NONINFECTIVE ENCEPHALITIS 2 0.0038
188 DRY MOUTH 245 0.0037
189 SLEEP DISORDER 202 0.0037
190 ADVERSE EVENT 281 0.0037
191 DEFORMITY 31 0.0037
192 RIGHT VENTRICULAR HYPERTROPHY 3 0.0036
193 DRUG EFFECT PROLONGED 2 0.0036
194 PRE-EXISTING CONDITION IMPROVED 21 0.0036
195 BLOOD OESTROGEN DECREASED 2 0.0036
196 RUBBER SENSITIVITY 4 0.0035
197 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 118 0.0035
198 SKIN OEDEMA 3 0.0035
199 SINUSITIS 292 0.0035
200 BONE DEMINERALISATION 3 0.0034
201 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0034
202 INFECTION 387 0.0034
203 ONYCHOMADESIS 9 0.0034
204 HYPOAESTHESIA 408 0.0032
205 BRONCHITIS BACTERIAL 2 0.0032
206 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2 0.0031
207 CATAPLEXY 4 0.0031
208 RECTAL POLYP 3 0.0031
209 HYPERTENSION 536 0.0031
210 VULVOVAGINAL CANDIDIASIS 3 0.0030
211 PERIPHERAL SWELLING 362 0.0030
212 KLEBSIELLA BACTERAEMIA 2 0.0030
213 ABDOMINAL SEPSIS 2 0.0030
214 PANCREATIC DISORDER 11 0.0029
215 THERAPEUTIC RESPONSE DECREASED 136 0.0028
216 PLATELET COUNT INCREASED 30 0.0028
217 CONFUSIONAL STATE 377 0.0028
218 EAR PAIN 43 0.0027
219 SPINAL DEFORMITY 4 0.0027
220 GINGIVAL ERYTHEMA 2 0.0027
221 NASOPHARYNGITIS 386 0.0026
222 DECREASED APPETITE 480 0.0026
223 THROMBOTIC THROMBOCYTOPENIC PURPURA 8 0.0026
224 NEURITIS 3 0.0026
225 FOOD AVERSION 3 0.0025
226 PRODUCT USE IN UNAPPROVED INDICATION 426 0.0025
227 MUSCLE SWELLING 2 0.0025
228 ASTHMA 204 0.0025
229 ULCER HAEMORRHAGE 14 0.0025
230 CONDITION AGGRAVATED 563 0.0025
231 INFECTED SKIN ULCER 4 0.0024
232 SCLERITIS 3 0.0024
233 DRUG HYPERSENSITIVITY 402 0.0024
234 MEDICATION ERROR 111 0.0024
235 ABDOMINAL PAIN UPPER 401 0.0024
236 SEIZURE LIKE PHENOMENA 3 0.0024
237 URTICARIA 311 0.0024
238 RASH 809 0.0023
239 MUSCLE CONTRACTURE 4 0.0023
240 ARTHRALGIA 745 0.0023
241 ARTHROPOD STING 3 0.0022
242 INTERVERTEBRAL DISC COMPRESSION 2 0.0022
243 ATTENTION DEFICIT HYPERACTIVITY DISORDER 4 0.0021
244 PAIN IN JAW 51 0.0021
245 OSTEOPOROSIS 72 0.0021
246 EATING DISORDER 37 0.0020
247 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 105 0.0020
248 INTERVERTEBRAL DISC OPERATION 2 0.0020
249 DACRYOSTENOSIS ACQUIRED 2 0.0020
250 BODY MASS INDEX INCREASED 2 0.0019
251 DRUG ERUPTION 27 0.0019
252 ARTHRITIS 125 0.0019
253 WEIGHT INCREASED 350 0.0019
254 DERMATITIS EXFOLIATIVE 9 0.0019
255 NAIL DISORDER 12 0.0019
256 BRONCHIAL HYPERREACTIVITY 2 0.0019
257 CONJUNCTIVITIS ALLERGIC 2 0.0019
258 DERMATITIS ALLERGIC 18 0.0019
259 CREPITATIONS 5 0.0019
260 GASTRIC ULCER PERFORATION 2 0.0018
261 PAIN 944 0.0018
262 OEDEMA PERIPHERAL 193 0.0018
263 VAGINAL INFECTION 7 0.0018
264 TUBERCULOSIS 19 0.0018
265 AMNESIA 100 0.0018
266 DYSPEPSIA 141 0.0018
267 MIGRAINE 131 0.0017
268 MUSCLE SPASTICITY 19 0.0017
269 GASTRIC ULCER 28 0.0017
270 LYMPHOCYTOSIS 3 0.0017
271 APPENDIX DISORDER 2 0.0017
272 DRUG-INDUCED LIVER INJURY 35 0.0017
273 PLEURITIC PAIN 4 0.0017
274 TENOSYNOVITIS 4 0.0017
275 IMPAIRED WORK ABILITY 31 0.0017
276 CHEST PAIN 258 0.0016
277 STAPHYLOCOCCAL SEPSIS 7 0.0016
278 WHITE BLOOD CELL COUNT INCREASED 53 0.0016
279 RHEUMATOID NODULE 4 0.0016
280 MUSCLE SPASMS 244 0.0016
281 OVERWEIGHT 7 0.0016
282 RESPIRATORY DISORDER 39 0.0016
283 POOR VENOUS ACCESS 12 0.0016
284 MOVEMENT DISORDER 41 0.0015
285 INCREASED TENDENCY TO BRUISE 12 0.0015
286 PARAESTHESIA 200 0.0015
287 PRODUCT COMPLAINT 23 0.0014
288 PLANTAR FASCIITIS 4 0.0014
289 OTITIS MEDIA 4 0.0014
290 IMPAIRED SELF-CARE 3 0.0014
291 VOMITING 539 0.0014
292 PAINFUL RESPIRATION 3 0.0014
293 RADICULOPATHY 3 0.0014
294 INAPPROPRIATE AFFECT 2 0.0014
295 LARGE INTESTINAL STENOSIS 2 0.0014
296 REACTION TO DRUG EXCIPIENTS 3 0.0014
297 LIVER FUNCTION TEST INCREASED 21 0.0014
298 HEADACHE 719 0.0014
299 OSTEOMALACIA 2 0.0014
300 TASTE DISORDER 17 0.0014
301 MEMORY IMPAIRMENT 158 0.0014
302 PRURITUS 378 0.0014
303 TACHYPHRENIA 4 0.0014
304 ULCERATIVE KERATITIS 3 0.0013
305 ACUTE SINUSITIS 2 0.0013
306 NASAL DISORDER 3 0.0013
307 HANGOVER 4 0.0013
308 COELIAC DISEASE 10 0.0013
309 FATIGUE 810 0.0013
310 HYPERPARATHYROIDISM SECONDARY 3 0.0013
311 VENTRICULAR HYPERTROPHY 3 0.0013
312 OFF LABEL USE 773 0.0013
313 DIZZINESS 527 0.0013
314 POST PROCEDURAL INFECTION 8 0.0013
315 MOTION SICKNESS 2 0.0013
316 GAIT DISTURBANCE 204 0.0013
317 ONYCHOCLASIS 7 0.0013
318 SYNOVIAL CYST 5 0.0012
319 NECK SURGERY 2 0.0012
320 SKIN EROSION 3 0.0012
321 TUBERCULIN TEST POSITIVE 3 0.0012
322 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0012
323 SLEEP APNOEA SYNDROME 20 0.0012
324 LARGE INTESTINE PERFORATION 7 0.0012
325 CUSHINGOID 3 0.0012
326 IRITIS 3 0.0012
327 NORMOCHROMIC NORMOCYTIC ANAEMIA 3 0.0012
328 RENAL CYST 8 0.0012
329 ERYTHEMA MULTIFORME 9 0.0012
330 TENSION HEADACHE 4 0.0011
331 PYREXIA 327 0.0011
332 MUSCULAR WEAKNESS 107 0.0011
333 RHINITIS ALLERGIC 4 0.0011
334 GASTROOESOPHAGEAL REFLUX DISEASE 73 0.0011
335 INJECTION SITE NECROSIS 2 0.0011
336 MALAISE 419 0.0011
337 NEUROLOGICAL DECOMPENSATION 2 0.0011
338 BODY TEMPERATURE FLUCTUATION 2 0.0011
339 WEIGHT DECREASED 256 0.0011
340 PERIODONTITIS 2 0.0011
341 TRICUSPID VALVE INCOMPETENCE 7 0.0011
342 FREQUENT BOWEL MOVEMENTS 22 0.0011
343 RASH VESICULAR 4 0.0011
344 EPILEPSY 26 0.0011
345 FINGER DEFORMITY 4 0.0011
346 PAIN IN EXTREMITY 268 0.0011
347 DISEASE RECURRENCE 37 0.0011
348 GLUCOSE TOLERANCE IMPAIRED 5 0.0011
349 GASTROINTESTINAL ULCER 2 0.0010
350 DRUG INEFFECTIVE 1132 0.0010
351 PEPTIC ULCER 3 0.0010
352 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0010
353 CONGENITAL ANOMALY 7 0.0010
354 CONJUNCTIVAL HYPERAEMIA 3 0.0010
355 ASTHENIA 320 0.0010
356 SKIN INFECTION 9 0.0010
357 FOOD INTOLERANCE 3 0.0010
358 ANAPHYLACTIC REACTION 43 0.0010
359 EYE DISORDER 27 0.0010
360 DERMATITIS BULLOUS 6 0.0010
361 BRONCHOSPASM 12 0.0010
362 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0010
363 BACK INJURY 8 0.0010
364 METASTASES TO LYMPH NODES 5 0.0010
365 CONCUSSION 6 0.0010
366 SNORING 3 0.0010
367 PNEUMONIA 243 0.0009
368 SPINAL PAIN 9 0.0009
369 CARTILAGE INJURY 2 0.0009
370 COLITIS ULCERATIVE 29 0.0009
371 TONGUE DISCOMFORT 3 0.0009
372 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0009
373 ESSENTIAL HYPERTENSION 2 0.0009
374 INFUSION SITE HAEMORRHAGE 2 0.0009
375 LARGE INTESTINAL ULCER 2 0.0009
376 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0009
377 DIARRHOEA 461 0.0009
378 CHOLECYSTITIS INFECTIVE 2 0.0009
379 BACK DISORDER 12 0.0009
380 CONJUNCTIVITIS 12 0.0009
381 MIGRAINE WITH AURA 2 0.0009
382 CRANIOCEREBRAL INJURY 2 0.0009
383 EJECTION FRACTION DECREASED 11 0.0008
384 RECTAL HAEMORRHAGE 31 0.0008
385 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
386 SPINAL COLUMN STENOSIS 4 0.0008
387 ABDOMINAL PAIN 161 0.0008
388 ANXIETY 202 0.0008
389 FOETAL EXPOSURE DURING PREGNANCY 54 0.0008
390 NAUSEA 532 0.0008
391 VISUAL IMPAIRMENT 79 0.0008
392 FLUID RETENTION 35 0.0008
393 CHONDROPATHY 2 0.0008
394 COMA SCALE ABNORMAL 2 0.0008
395 UPPER RESPIRATORY TRACT INFECTION 30 0.0008
396 FIBULA FRACTURE 2 0.0008
397 PHARYNGEAL SWELLING 5 0.0008
398 DYSPHEMIA 3 0.0008
399 BODY TEMPERATURE INCREASED 14 0.0008
400 NECK INJURY 2 0.0008
401 DUODENAL ULCER HAEMORRHAGE 2 0.0008
402 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0008
403 DYSPNOEA 364 0.0008
404 MUSCULOSKELETAL DISCOMFORT 11 0.0008
405 CYST 8 0.0008
406 DUODENITIS 2 0.0008
407 IMMUNE THROMBOCYTOPENIA 2 0.0008
408 TIBIA FRACTURE 3 0.0008
409 DEPRESSION 151 0.0008
410 EYE PAIN 32 0.0008
411 LIGAMENT SPRAIN 6 0.0008
412 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
413 RENAL TUBULAR NECROSIS 6 0.0007
414 INFUSION SITE EXTRAVASATION 4 0.0007
415 FOOT FRACTURE 12 0.0007
416 HEPATITIS ACUTE 4 0.0007
417 PHOTOPHOBIA 11 0.0007
418 WEIGHT FLUCTUATION 6 0.0007
419 GASTRITIS EROSIVE 3 0.0007
420 NERVE INJURY 7 0.0007
421 HYPOPNOEA 2 0.0007
422 BRAIN INJURY 6 0.0007
423 ATELECTASIS 6 0.0007
424 LOOSE TOOTH 2 0.0007
425 PARANASAL SINUS DISCOMFORT 2 0.0007
426 RESTLESS LEGS SYNDROME 11 0.0007
427 PATHOLOGICAL FRACTURE 3 0.0007
428 LABORATORY TEST ABNORMAL 17 0.0007
429 RESPIRATORY TRACT INFECTION 14 0.0007
430 MUSCULOSKELETAL CHEST PAIN 9 0.0007
431 BASAL CELL CARCINOMA 9 0.0007
432 CHEST X-RAY ABNORMAL 2 0.0007
433 HORDEOLUM 2 0.0007
434 BODY TEMPERATURE DECREASED 6 0.0007
435 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0007
436 CHRONIC SINUSITIS 2 0.0007
437 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0007
438 HEART RATE ABNORMAL 3 0.0007
439 SKIN LESION 15 0.0007
440 AMYLASE INCREASED 2 0.0007
441 BRUXISM 3 0.0007
442 INSOMNIA 151 0.0007
443 SPINAL OSTEOARTHRITIS 5 0.0007
444 TREATMENT NONCOMPLIANCE 27 0.0007
445 GASTRIC INFECTION 2 0.0006
446 NECK PAIN 30 0.0006
447 BRONCHITIS 41 0.0006
448 ARTERIOSPASM CORONARY 2 0.0006
449 HAEMORRHAGIC DIATHESIS 2 0.0006
450 HAEMATEMESIS 14 0.0006
451 EXERCISE TOLERANCE DECREASED 3 0.0006
452 OESOPHAGEAL CANDIDIASIS 2 0.0006
453 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0006
454 FEELING HOT 33 0.0006
455 APHONIA 7 0.0006
456 BEDRIDDEN 7 0.0006
457 GALLBLADDER OPERATION 2 0.0006
458 BACK PAIN 122 0.0006
459 ESCHERICHIA INFECTION 4 0.0006
460 FEAR OF INJECTION 3 0.0006
461 FUNGAL SKIN INFECTION 2 0.0006
462 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0006
463 FEELING DRUNK 4 0.0006
464 FAECES SOFT 3 0.0006
465 SPINAL OPERATION 5 0.0006
466 ORAL INFECTION 2 0.0006
467 EXPOSURE VIA SKIN CONTACT 2 0.0006
468 PALLOR 14 0.0006
469 ANAPHYLACTIC SHOCK 12 0.0006
470 HEPATIC NECROSIS 2 0.0006
471 PANIC DISORDER 2 0.0006
472 HYPERURICAEMIA 2 0.0006
473 ARTHRITIS BACTERIAL 2 0.0006
474 COLITIS MICROSCOPIC 2 0.0006
475 MYOSITIS 4 0.0006
476 PERIPHERAL ISCHAEMIA 2 0.0006
477 ENERGY INCREASED 3 0.0006
478 NEUTROPHIL COUNT INCREASED 5 0.0006
479 LIMB OPERATION 2 0.0006
480 NEPHROLITHIASIS 21 0.0006
481 PYELONEPHRITIS 4 0.0006
482 ANHEDONIA 14 0.0006
483 UNDERDOSE 34 0.0006
484 SCOLIOSIS 3 0.0006
485 GASTROENTERITIS VIRAL 8 0.0006
486 TOOTH ABSCESS 5 0.0006
487 COLITIS 16 0.0006
488 ILEUS PARALYTIC 2 0.0006
489 BLOOD URINE PRESENT 9 0.0006
490 VITAMIN D DECREASED 4 0.0005
491 RESPIRATORY RATE INCREASED 4 0.0005
492 AUTOIMMUNE HEPATITIS 3 0.0005
493 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0005
494 GASTRIC DISORDER 19 0.0005
495 GASTRITIS 12 0.0005
496 ABNORMAL SENSATION IN EYE 2 0.0005
497 LIGAMENT RUPTURE 2 0.0005
498 BURNING SENSATION 32 0.0005
499 END STAGE RENAL DISEASE 9 0.0005
500 GINGIVAL SWELLING 2 0.0005
501 INCOHERENT 3 0.0005
502 GENERALISED ERYTHEMA 3 0.0005
503 HEPATITIS 11 0.0005
504 ACCIDENT 5 0.0005
505 DYSSTASIA 13 0.0005
506 HYPOVOLAEMIC SHOCK 2 0.0005
507 DRY EYE 17 0.0005
508 CARPAL TUNNEL SYNDROME 6 0.0005
509 FLANK PAIN 4 0.0005
510 OXYGEN SATURATION DECREASED 22 0.0005
511 SKIN HAEMORRHAGE 5 0.0005
512 HAND FRACTURE 3 0.0005
513 MAJOR DEPRESSION 3 0.0005
514 PERFORMANCE STATUS DECREASED 2 0.0005
515 DISSOCIATION 2 0.0005
516 PANCREATITIS 22 0.0005
517 RASH ERYTHEMATOUS 17 0.0005
518 ORAL CANDIDIASIS 5 0.0005
519 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0005
520 ARTHROPOD BITE 3 0.0005
521 TOXIC EPIDERMAL NECROLYSIS 6 0.0005
522 BONE DISORDER 8 0.0005
523 NEPHROPATHY 4 0.0005
524 HUMERUS FRACTURE 2 0.0005
525 PNEUMONITIS 10 0.0005
526 SEASONAL ALLERGY 5 0.0005
527 IMPAIRED GASTRIC EMPTYING 3 0.0005
528 ILLNESS 25 0.0005
529 SURGERY 20 0.0005
530 UPPER-AIRWAY COUGH SYNDROME 3 0.0005
531 STEVENS-JOHNSON SYNDROME 9 0.0005
532 RHINITIS 3 0.0005
533 HOSPITALISATION 52 0.0005
534 PETECHIAE 4 0.0005
535 LYMPHOMA 6 0.0005
536 NEPHROGENIC ANAEMIA 2 0.0005
537 RASH PUSTULAR 3 0.0005
538 DIABETIC NEUROPATHY 2 0.0004
539 DRUG INTERACTION 60 0.0004
540 LOCALISED INFECTION 9 0.0004
541 CYANOSIS 6 0.0004
542 BLOOD IRON DECREASED 4 0.0004
543 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
544 DEEP VEIN THROMBOSIS 26 0.0004
545 DRUG RESISTANCE 9 0.0004
546 PSORIASIS 49 0.0004
547 SINUS CONGESTION 5 0.0004
548 HIATUS HERNIA 5 0.0004
549 OSTEOMYELITIS 7 0.0004
550 DRUG EFFECT DELAYED 2 0.0004
551 HYSTERECTOMY 3 0.0004
552 APNOEA 3 0.0004
553 HYPERKERATOSIS 2 0.0004
554 SEIZURE 38 0.0004
555 MOUTH SWELLING 2 0.0004
556 GINGIVITIS 2 0.0004
557 MICTURITION URGENCY 4 0.0004
558 NYSTAGMUS 2 0.0004
559 PANIC ATTACK 13 0.0004
560 VIRAL INFECTION 11 0.0004
561 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 47 0.0004
562 FEELING JITTERY 7 0.0004
563 PRODUCT PRESCRIBING ERROR 7 0.0004
564 MASS 5 0.0004
565 LIMB INJURY 9 0.0004
566 BIPOLAR DISORDER 4 0.0004
567 PRODUCTIVE COUGH 15 0.0004
568 MOUTH ULCERATION 7 0.0004
569 IMPAIRED DRIVING ABILITY 4 0.0004
570 INTERNAL HAEMORRHAGE 4 0.0004
571 SWOLLEN TONGUE 11 0.0004
572 NEURALGIA 8 0.0004
573 ANGIOPATHY 2 0.0004
574 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0004
575 INTENTIONAL PRODUCT MISUSE 29 0.0004
576 BODY HEIGHT DECREASED 4 0.0004
577 GENERALISED OEDEMA 4 0.0004
578 ECONOMIC PROBLEM 6 0.0004
579 THERAPY PARTIAL RESPONDER 3 0.0004
580 UVEITIS 4 0.0004
581 WRIST FRACTURE 4 0.0004
582 HEART RATE DECREASED 12 0.0004
583 IRON DEFICIENCY ANAEMIA 3 0.0004
584 SPUTUM DISCOLOURED 3 0.0004
585 NERVE COMPRESSION 3 0.0004
586 HERPES ZOSTER 19 0.0004
587 TUBULOINTERSTITIAL NEPHRITIS 6 0.0004
588 MENTAL IMPAIRMENT 8 0.0004
589 INFLUENZA 33 0.0004
590 INGUINAL HERNIA 2 0.0004
591 MENISCUS INJURY 2 0.0004
592 DECREASED INTEREST 2 0.0004
593 MENTAL DISORDER 14 0.0004
594 GASTRIC HAEMORRHAGE 4 0.0004
595 HYPERTONIA 2 0.0004
596 BLOOD PRESSURE FLUCTUATION 8 0.0004
597 DIARRHOEA HAEMORRHAGIC 3 0.0004
598 FAECES DISCOLOURED 7 0.0004
599 OSTEOPENIA 5 0.0004
600 FRACTURE 6 0.0004
601 TOOTH EXTRACTION 4 0.0004
602 VITAMIN D DEFICIENCY 3 0.0004
603 NODULE 4 0.0004
604 SWELLING FACE 20 0.0004
605 TEMPERATURE INTOLERANCE 3 0.0004
606 MELAENA 7 0.0004
607 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0004
608 ROTATOR CUFF SYNDROME 4 0.0004
609 SUICIDAL IDEATION 28 0.0004
610 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0004
611 QUALITY OF LIFE DECREASED 4 0.0004
612 PSYCHOLOGICAL TRAUMA 3 0.0004
613 CHRONIC KIDNEY DISEASE 25 0.0004
614 APHTHOUS ULCER 2 0.0004
615 OROPHARYNGEAL PAIN 27 0.0004
616 BLOOD POTASSIUM DECREASED 9 0.0004
617 TACHYCARDIA 26 0.0004
618 DYSGRAPHIA 2 0.0004
619 RIB FRACTURE 6 0.0004
620 SKIN REACTION 4 0.0004
621 STAPHYLOCOCCAL INFECTION 10 0.0004
622 FALL 96 0.0003
623 PARAESTHESIA ORAL 4 0.0003
624 HAIR GROWTH ABNORMAL 2 0.0003
625 CEREBRAL DISORDER 2 0.0003
626 OVARIAN CYST 3 0.0003
627 DUODENAL ULCER 2 0.0003
628 SKIN FISSURES 4 0.0003
629 HUNGER 3 0.0003
630 SPEECH DISORDER 15 0.0003
631 TOOTHACHE 5 0.0003
632 OESOPHAGITIS 3 0.0003
633 PANCREATITIS ACUTE 6 0.0003
634 GASTROENTERITIS 4 0.0003
635 TOOTH LOSS 6 0.0003
636 HEPATIC STEATOSIS 5 0.0003
637 MULTIPLE ALLERGIES 2 0.0003
638 CYSTITIS 9 0.0003
639 RASH PRURITIC 14 0.0003
640 OROPHARYNGEAL DISCOMFORT 2 0.0003
641 HERNIA 5 0.0003
642 ABASIA 8 0.0003
643 DISEASE PROGRESSION 30 0.0003
644 SKIN ULCER 7 0.0003
645 PAROSMIA 2 0.0003
646 COORDINATION ABNORMAL 4 0.0003
647 RENAL INJURY 9 0.0003
648 THYROID DISORDER 4 0.0003
649 HYPONATRAEMIA 15 0.0003
650 NOCTURIA 3 0.0003
651 METABOLIC ACIDOSIS 8 0.0003
652 RENAL IMPAIRMENT 21 0.0003
653 LIPASE INCREASED 2 0.0003
654 PNEUMOTHORAX 4 0.0003
655 RASH PAPULAR 6 0.0003
656 ANKLE FRACTURE 4 0.0003
657 THROAT IRRITATION 11 0.0003
658 GENERAL SYMPTOM 2 0.0003
659 DIABETES MELLITUS 20 0.0003
660 ASPHYXIA 2 0.0003
661 EOSINOPHIL COUNT INCREASED 2 0.0003
662 CARDIO-RESPIRATORY ARREST 11 0.0003
663 AORTIC ANEURYSM 2 0.0003
664 RED BLOOD CELL COUNT DECREASED 7 0.0003
665 STRESS 17 0.0003
666 PRODUCT ADMINISTRATION ERROR 4 0.0003
667 HEAD DISCOMFORT 4 0.0003
668 AGEUSIA 6 0.0003
669 DECUBITUS ULCER 2 0.0003
670 VISION BLURRED 32 0.0003
671 KNEE OPERATION 2 0.0003
672 IMMUNODEFICIENCY 3 0.0003
673 SKIN DISCOLOURATION 11 0.0003
674 JOINT INJURY 5 0.0003
675 GINGIVAL BLEEDING 3 0.0003
676 HEPATOTOXICITY 5 0.0003
677 RENAL FAILURE ACUTE 12 0.0003
678 MYDRIASIS 3 0.0003
679 PULMONARY CONGESTION 3 0.0003
680 DECREASED IMMUNE RESPONSIVENESS 2 0.0003
681 EMBOLISM 2 0.0003
682 CELLULITIS 12 0.0003
683 THROMBOSIS 19 0.0003
684 TOOTH INFECTION 3 0.0003
685 PULMONARY EMBOLISM 23 0.0003
686 MUSCLE STRAIN 2 0.0003
687 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0003
688 RHINORRHOEA 14 0.0003
689 FULL BLOOD COUNT ABNORMAL 2 0.0003
690 LIMB DISCOMFORT 7 0.0003
691 LYMPHADENOPATHY 8 0.0003
692 APPENDICITIS 2 0.0003
693 FACIAL PAIN 2 0.0003
694 UNEVALUABLE EVENT 18 0.0003
695 BLOOD CALCIUM INCREASED 2 0.0003
696 NEUROPATHY PERIPHERAL 20 0.0003
697 HEAD INJURY 7 0.0003
698 HOSPICE CARE 2 0.0003
699 MULTIPLE FRACTURES 4 0.0003
700 GROIN PAIN 2 0.0003
701 BLOOD PRESSURE INCREASED 34 0.0003
702 ORAL HERPES 4 0.0003
703 EYE HAEMORRHAGE 3 0.0003
704 AKATHISIA 3 0.0003
705 TOOTH DISORDER 5 0.0003
706 INTENTIONAL OVERDOSE 13 0.0003
707 BLOOD PRESSURE ABNORMAL 4 0.0003
708 RHABDOMYOLYSIS 9 0.0003
709 COMPLETED SUICIDE 19 0.0003
710 DISTURBANCE IN ATTENTION 12 0.0003
711 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0003
712 RESPIRATORY DISTRESS 6 0.0003
713 LUNG INFECTION 4 0.0003
714 RESTLESSNESS 8 0.0003
715 FUNGAL INFECTION 7 0.0003
716 OCULAR HYPERAEMIA 9 0.0003
717 DERMATITIS ATOPIC 4 0.0003
718 SINUS TACHYCARDIA 3 0.0003
719 SEDATION 5 0.0002
720 COUGH 55 0.0002
721 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
722 BONE DENSITY DECREASED 7 0.0002
723 SINUS DISORDER 4 0.0002
724 FEELING ABNORMAL 51 0.0002
725 EAR DISCOMFORT 2 0.0002
726 HYPERBILIRUBINAEMIA 2 0.0002
727 NASAL CONGESTION 11 0.0002
728 ADRENAL INSUFFICIENCY 2 0.0002
729 TREMOR 34 0.0002
730 DYSPHAGIA 18 0.0002
731 SUICIDE ATTEMPT 12 0.0002
732 ECZEMA 6 0.0002
733 NEPHROPATHY TOXIC 2 0.0002
734 BLADDER DISORDER 2 0.0002
735 HEPATOCELLULAR INJURY 3 0.0002
736 ACUTE KIDNEY INJURY 28 0.0002
737 VERTIGO 12 0.0002
738 GASTROINTESTINAL CARCINOMA 2 0.0002
739 HYPOTONIA 2 0.0002
740 BALANCE DISORDER 17 0.0002
741 MULTI-ORGAN FAILURE 4 0.0002
742 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
743 HAEMOGLOBIN DECREASED 20 0.0002
744 SNEEZING 4 0.0002
745 HYPOTENSION 38 0.0002
746 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
747 ULCER 3 0.0002
748 TENDONITIS 3 0.0002
749 EUPHORIC MOOD 2 0.0002
750 DERMATITIS CONTACT 2 0.0002
751 ANGIOEDEMA 8 0.0002
752 HAEMATOMA 5 0.0002
753 BLOOD POTASSIUM INCREASED 3 0.0002
754 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
755 INFUSION SITE PAIN 2 0.0002
756 GRAND MAL CONVULSION 2 0.0002
757 CHOLECYSTECTOMY 2 0.0002
758 BLOOD CREATININE INCREASED 12 0.0002
759 EOSINOPHILIA 3 0.0002
760 SYNCOPE 18 0.0002
761 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
762 INJECTION SITE REACTION 12 0.0002
763 MYALGIA 30 0.0002
764 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
765 BLOOD GLUCOSE FLUCTUATION 2 0.0002
766 DEVICE OCCLUSION 2 0.0002
767 INTERSTITIAL LUNG DISEASE 8 0.0002
768 COVID-19 27 0.0002
769 FACE OEDEMA 3 0.0002
770 BLOOD CALCIUM DECREASED 2 0.0002
771 EPISTAXIS 13 0.0002
772 CONSTIPATION 35 0.0002
773 NEOPLASM MALIGNANT 11 0.0002
774 LACTIC ACIDOSIS 5 0.0002
775 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
776 URINARY TRACT INFECTION 28 0.0002
777 LOSS OF CONSCIOUSNESS 22 0.0002
778 DYSPNOEA EXERTIONAL 6 0.0002
779 PARANOIA 3 0.0002
780 LEUKOCYTOSIS 3 0.0002
781 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
782 COLD SWEAT 3 0.0002
783 BLOOD UREA INCREASED 3 0.0002
784 INJECTION SITE DISCOLOURATION 2 0.0002
785 ENCEPHALOPATHY 4 0.0002
786 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
787 HYPOTHYROIDISM 5 0.0002
788 CARDIAC DISORDER 16 0.0002
789 EYE SWELLING 6 0.0002
790 IMPAIRED QUALITY OF LIFE 2 0.0002
791 PNEUMONIA ASPIRATION 4 0.0002
792 HYPERGLYCAEMIA 6 0.0002
793 BLOOD COUNT ABNORMAL 3 0.0002
794 DERMATITIS 3 0.0002
795 RENAL FAILURE 23 0.0002
796 GALLBLADDER DISORDER 3 0.0002
797 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
798 PRODUCT DOSE OMISSION ISSUE 29 0.0002
799 LIVER FUNCTION TEST ABNORMAL 5 0.0002
800 DIPLOPIA 4 0.0002
801 LIBIDO DECREASED 2 0.0002
802 UNRESPONSIVE TO STIMULI 4 0.0002
803 ACUTE HEPATIC FAILURE 2 0.0002
804 SKIN DISORDER 5 0.0002
805 KIDNEY INFECTION 3 0.0002
806 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
807 DRUG ABUSE 13 0.0002
808 POST PROCEDURAL COMPLICATION 3 0.0002
809 BONE PAIN 9 0.0002
810 CHOLELITHIASIS 5 0.0002
811 BLOOD TEST ABNORMAL 2 0.0002
812 SOMNOLENCE 30 0.0002
813 MOOD SWINGS 5 0.0002
814 CARDIOMEGALY 2 0.0002
815 THERAPEUTIC RESPONSE SHORTENED 3 0.0002
816 HYPOACUSIS 6 0.0002
817 THROMBOCYTOPENIA 16 0.0002
818 DIVERTICULITIS 4 0.0002
819 ACCIDENTAL OVERDOSE 5 0.0002
820 HEPATITIS C 2 0.0002
821 THERAPY CESSATION 7 0.0002
822 FLATULENCE 8 0.0002
823 DISORIENTATION 6 0.0002
824 RETCHING 3 0.0002
825 CHILLS 17 0.0002
826 SEPSIS 16 0.0002
827 BLINDNESS UNILATERAL 2 0.0002
828 EYE PRURITUS 4 0.0002
829 MULTIPLE SCLEROSIS 7 0.0002
830 HAEMATOCRIT DECREASED 3 0.0002
831 HYPERSOMNIA 4 0.0002
832 MENTAL STATUS CHANGES 4 0.0002
833 EMOTIONAL DISTRESS 19 0.0002
834 RASH MACULO-PAPULAR 3 0.0002
835 JAUNDICE 4 0.0002
836 NIGHTMARE 5 0.0002
837 ANGER 5 0.0002
838 APATHY 2 0.0002
839 DEPRESSED MOOD 7 0.0002
840 NO THERAPEUTIC RESPONSE 2 0.0002
841 SHOCK 3 0.0002
842 LETHARGY 8 0.0002
843 FEAR 4 0.0002
844 ASCITES 4 0.0002
845 ABNORMAL DREAMS 4 0.0002
846 TRANSAMINASES INCREASED 3 0.0002
847 GENERALISED TONIC-CLONIC SEIZURE 2 0.0002
848 DEHYDRATION 18 0.0002
849 CARDIOMYOPATHY 2 0.0002
850 HYPOAESTHESIA ORAL 2 0.0002
851 ORAL PAIN 3 0.0002
852 WHITE BLOOD CELL COUNT DECREASED 14 0.0002
853 CANDIDA INFECTION 2 0.0002
854 COGNITIVE DISORDER 6 0.0002
855 TINNITUS 6 0.0002
856 CHROMATURIA 3 0.0002
857 CRYING 5 0.0002
858 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0002
859 RASH GENERALISED 4 0.0002
860 RENAL DISORDER 6 0.0002
861 PRESYNCOPE 3 0.0002
862 BLINDNESS 5 0.0002
863 MUSCLE TWITCHING 3 0.0002
864 WITHDRAWAL SYNDROME 5 0.0002
865 NERVOUSNESS 7 0.0001
866 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
867 DRUG EFFECT DECREASED 8 0.0001
868 BONE LOSS 2 0.0001
869 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
870 INJECTION SITE PRURITUS 8 0.0001
871 DRUG TOXICITY 2 0.0001
872 HEART RATE INCREASED 12 0.0001
873 DYSKINESIA 5 0.0001
874 FEMUR FRACTURE 4 0.0001
875 ERUCTATION 2 0.0001
876 DRUG LEVEL INCREASED 2 0.0001
877 RASH MACULAR 4 0.0001
878 ABORTION SPONTANEOUS 5 0.0001
879 INCREASED APPETITE 2 0.0001
880 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
881 ABDOMINAL DISTENSION 12 0.0001
882 CORONARY ARTERY DISEASE 4 0.0001
883 HYPOXIA 4 0.0001
884 ERYTHEMA 24 0.0001
885 DEMENTIA 3 0.0001
886 HYPERKALAEMIA 4 0.0001
887 PRURITUS GENERALISED 3 0.0001
888 DYSGEUSIA 9 0.0001
889 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
890 HYPERHIDROSIS 15 0.0001
891 ORTHOSTATIC HYPOTENSION 2 0.0001
892 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
893 LYMPHOCYTE COUNT DECREASED 2 0.0001
894 GOUT 2 0.0001
895 MIDDLE INSOMNIA 2 0.0001
896 OSTEONECROSIS OF JAW 3 0.0001
897 HALLUCINATION 8 0.0001
898 CIRCULATORY COLLAPSE 2 0.0001
899 PANCYTOPENIA 6 0.0001
900 THROAT TIGHTNESS 3 0.0001
901 ACUTE RESPIRATORY FAILURE 2 0.0001
902 PULMONARY OEDEMA 5 0.0001
903 LACRIMATION INCREASED 3 0.0001
904 PRODUCT QUALITY ISSUE 16 0.0001
905 CATARACT 6 0.0001
906 BLOOD SODIUM DECREASED 2 0.0001
907 DYSURIA 4 0.0001
908 HAEMOPTYSIS 3 0.0001
909 BLOOD PRESSURE DECREASED 7 0.0001
910 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
911 FULL BLOOD COUNT DECREASED 2 0.0001
912 DYSARTHRIA 4 0.0001
913 PLASMA CELL MYELOMA 4 0.0001
914 GLAUCOMA 2 0.0001
915 EYE IRRITATION 5 0.0001
916 PALPITATIONS 12 0.0001
917 PRODUCT DOSE OMISSION 8 0.0001
918 RESPIRATORY ARREST 3 0.0001
919 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
920 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
921 INJECTION SITE ERYTHEMA 12 0.0001
922 ANGINA PECTORIS 3 0.0001
923 HEPATIC FAILURE 3 0.0001
924 POLLAKIURIA 4 0.0001
925 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
926 RESPIRATORY FAILURE 7 0.0001
927 HAEMATOCHEZIA 5 0.0001
928 HIP FRACTURE 3 0.0001
929 THERAPY INTERRUPTED 4 0.0001
930 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
931 ANAEMIA 18 0.0001
932 INJECTION SITE WARMTH 2 0.0001
933 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
934 DRUG EFFECT INCOMPLETE 4 0.0001
935 URINARY RETENTION 3 0.0001
936 AGITATION 7 0.0001
937 CHEST DISCOMFORT 9 0.0001
938 NERVOUS SYSTEM DISORDER 3 0.0001
939 CEREBROVASCULAR ACCIDENT 16 0.0001
940 INCORRECT DOSE ADMINISTERED 17 0.0001
941 DYSPHONIA 5 0.0001
942 NEEDLE ISSUE 2 0.0001
943 OVERDOSE 19 0.0001
944 FLUSHING 9 0.0001
945 DIABETIC KETOACIDOSIS 2 0.0001
946 OSTEONECROSIS 3 0.0001
947 HEART RATE IRREGULAR 2 0.0001
948 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
949 INFLUENZA LIKE ILLNESS 7 0.0001
950 INJECTION SITE BRUISING 6 0.0001
951 FEBRILE NEUTROPENIA 5 0.0001
952 BLOOD GLUCOSE INCREASED 15 0.0001
953 MOOD ALTERED 2 0.0001
954 SEPTIC SHOCK 3 0.0001
955 BRADYCARDIA 4 0.0001
956 PAIN OF SKIN 2 0.0001
957 INJECTION SITE SWELLING 5 0.0001
958 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
959 APPLICATION SITE ERYTHEMA 2 0.0001
960 TOXICITY TO VARIOUS AGENTS 11 0.0001
961 NO ADVERSE EVENT 10 0.0001
962 DRY SKIN 8 0.0001
963 ACUTE MYOCARDIAL INFARCTION 2 0.0001
964 IRRITABILITY 4 0.0001
965 EMOTIONAL DISORDER 2 0.0001
966 COMA 3 0.0001
967 ATRIAL FIBRILLATION 6 0.0001
968 ARRHYTHMIA 3 0.0001
969 HYPOGLYCAEMIA 3 0.0001
970 LIP SWELLING 2 0.0001
971 BLOOD GLUCOSE DECREASED 3 0.0001
972 CARDIAC ARREST 5 0.0001
973 INJECTION SITE PAIN 16 0.0001
974 DEATH 49 0.0001
975 AGGRESSION 3 0.0001
976 INJECTION SITE MASS 2 0.0001
977 PLATELET COUNT DECREASED 6 0.0001
978 SKIN BURNING SENSATION 4 0.0001
979 CEREBRAL HAEMORRHAGE 2 0.0001
980 DRUG ADMINISTRATION ERROR 2 0.0001
981 SKIN EXFOLIATION 4 0.0001
982 PRODUCT SUBSTITUTION ISSUE 3 0.0001
983 ACNE 4 0.0001
984 HAEMORRHAGE 5 0.0001
985 PLEURAL EFFUSION 3 0.0001
986 DEVICE DISLOCATION 2 0.0001
987 DRUG DOSE OMISSION 9 0.0001
988 HYPOKALAEMIA 2 0.0001
989 DRUG DEPENDENCE 8 0.0001
990 HOT FLUSH 3 0.0001
991 LEUKOPENIA 2 0.0000
992 MYOCARDIAL INFARCTION 7 0.0000
993 CARDIAC FAILURE CONGESTIVE 3 0.0000
994 PROSTATE CANCER 3 0.0000
995 CARDIAC FAILURE 2 0.0000
996 DRUG WITHDRAWAL SYNDROME 2 0.0000
997 BREAST CANCER 2 0.0000
998 NEUTROPENIA 2 0.0000